Cat. No.: DAA-001191
Product Information | |
---|---|
Product Name | Human IL-6 Rα Antibody Pair - BSA and Azide free |
Species | Human |
Description | Human IL-6Rα Antibody Pair is a matched pair of unconjugated recombinant rabbit monoclonal capture and detection antibodies used to quantify Human IL-6Rα in sandwich ELISAs and many other pair-based applications. |
Detection Range | 125 pg/mL - 8000 pg/mL |
Target Information | |
---|---|
Target Name | IL6 |
UniProt No. | P05231 |
Gene ID | 3569 |
Target Description | Cytokine with a wide variety of biological functions. It is a potent inducer of the acute phase response. Plays an essential role in the final differentiation of B-cells into Ig-secreting cells Involved in lymphocyte and monocyte differentiation. It induces myeloma and plasmacytoma growth and induces nerve cells differentiation Acts on B-cells, T-cells, hepatocytes, hematopoeitic progenitor cells and cells of the CNS. Also acts as a myokine. It is discharged into the bloodstream after muscle contraction and acts to increase the breakdown of fats and to improve insulin resistance. |
Alternative Names | Interleukin BSF 2; B cell differentiation factor; B cell stimulatory factor 2; B-cell stimulatory factor 2; BSF 2; BSF-2; BSF2; CDF; CTL differentiation factor; Cytotoxic T cell differentiation factor; Hepatocyte stimulating factor; Hepatocyte stimulatory factor; HGF; HSF; Hybridoma growth factor; Hybridoma growth factor Interferonβ-2; Hybridoma plasmacytoma growth factor; IFN-β-2; IFNB2; IL 6; IL-6; IL6; IL6_HUMAN; Interferonβ 2; Interferonβ-2; Interleukin 6; Interleukin 6 (interferonβ 2); Interleukin BSF 2; Interleukin-6 |
Shipping & Storage | |
---|---|
Sipping | Shipping on dry ice. |
Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.